Unlabelled: Familial Mediterranean fever (FMF) is traditionally associated with biallelic mutations in the MEFV gene; however, heterozygous mutations may also contribute to disease phenotypes. We report the case of a 42-year-old woman with heterozygous p.Met694Ile MEFV mutation, presenting with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system and lungs. Her clinical course was marked by immune dysregulation, autoimmunity and inflammatory manifestations, including urticarial neutrophilic dermatoses and IgM deficiency. This case highlights the potential pathogenic role of heterozygous MEFV mutations in ANCA-associated vasculitis, expanding the clinical spectrum of FMF-related inflammatory diseases. Genetic investigation is essential in patients with overlapping autoimmune and autoinflammatory features to guide appropriate diagnosis and management.

Learning Points: Systemic vasculitis may be associated with MEFV mutations as a spectrum of the clinical presentation of familial Mediterranean fever.MEFV heterozygous mutations may be associated with manifestations of immune dysregulation.Beware of inborn errors of immunity even in adult patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11882008PMC
http://dx.doi.org/10.12890/2025_005127DOI Listing

Publication Analysis

Top Keywords

anca-associated vasculitis
12
mefv mutation
8
vasculitis involving
8
involving central
8
central nervous
8
nervous system
8
system lungs
8
familial mediterranean
8
heterozygous mutations
8
mefv mutations
8

Similar Publications

Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) both present with hypereosinophilia and organ damage induced by eosinophils. EGPA is also characterized by vasculitis and is associated with ANCA. Yet, discriminating HES from EGPA may be difficult in clinical practice as biomarkers to reliably differentiate between HES and EGPA are still lacking.

View Article and Find Full Text PDF

ANCA-associated vasculitis (AAV) is a heterogeneous autoimmune disease marked by varying organ involvement and outcomes. Plasma exchange, a method of removing native plasma and replacing it with crystalloid, albumin or donor plasma, can deplete autoantibodies and may help control autoimmune diseases rapidly. In AAV, several randomized controlled trials have been performed but, individually, had mixed results.

View Article and Find Full Text PDF

Polyarteritis nodosa (PAN) was first described in 1852 with the first widely recognised description in 1866 by Kussmaul and Meier. Since then our concepts of the condition have evolved, with recognition of the difference between polyarteritis nodosa and microscopic polyangiitis (MPA). Classification criteria for PAN remain unsatisfactory.

View Article and Find Full Text PDF

Emerging targeted therapies in ANCA-associated vasculitis.

Rheumatology (Oxford)

March 2025

Department of Medicine, University of Cambridge, Cambridge, UK.

Drug development in ANCA-associated vasculitis has aimed to improve on the success of the B cell depleting monoclonal antibody rituximab and exploit better understanding of inflammatory pathways. More potent B cell depletion strategies are being tested as are B cell cytokine inhibitors. The involvement of the complement system in pathogenesis is more complicated than previously thought and extends beyond C5a dysregulation and its inhibition with avacopan, broader complement inhibitors and complement regulatory agonists are potential newer therapies.

View Article and Find Full Text PDF

The evolving landscape of vasculitis management: past, current and emerging.

Rheumatology (Oxford)

March 2025

UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Our understanding of ANCA vasculitis has advanced from discovery of putative auto-antibodies to a greater understanding of the myriad alterations of innate and adaptive immunity in this disease. The 21st International Vasculitis Workshop held in Barcelona served again as a forum for distributing and sharing advances in this field. B-cell and T-cell subsets are skewed in ANCA vasculitis patients, favoring a pro-inflammatory phenotype.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!